Malaria

GSK to seek green light for malaria vaccine

British drug maker GlaxoSmithKline (GSK) said on Tuesday it hoped to get the green light for a prototype vaccine against malaria after trials showed it offered children a partial shield against the disease.

Oct 08, 2013
popularity not rated yet | comments 0

Latest Spotlight News

From chick to bedside: Removing the Wnt barrier

Kick starting a process that might repair the damage done in cerebral palsy and multiple sclerosis could begin with disabling a driver that helps block regeneration, said Baylor College of Medicine researchers ...

Just a half hour of lost sleep linked weight gain

(HealthDay)—Think twice the next time you don't get as much sleep as you need: A new study suggests that missing just 30 minutes of shuteye during weeknights could boost your weight and disrupt your metabolism.